SGMS2 and influenza: A plausible explanation is that these pre‐vaccination levels represent pre‐existing cross‐reactive A(H1N1)pdm09‐specific ADCC antibodies (and to a lesser extent CDL antibodies) induced by previous seasonal influenza infection, rather than due to previous pandemic influenza infection.